EA201900453A3 - TEST SYSTEM FOR STUDIES OF HEMOSTATIC PROPERTIES OF LOCAL WOUND COATINGS IN VITRO - Google Patents

TEST SYSTEM FOR STUDIES OF HEMOSTATIC PROPERTIES OF LOCAL WOUND COATINGS IN VITRO

Info

Publication number
EA201900453A3
EA201900453A3 EA201900453A EA201900453A EA201900453A3 EA 201900453 A3 EA201900453 A3 EA 201900453A3 EA 201900453 A EA201900453 A EA 201900453A EA 201900453 A EA201900453 A EA 201900453A EA 201900453 A3 EA201900453 A3 EA 201900453A3
Authority
EA
Eurasian Patent Office
Prior art keywords
vitro
studies
microtube
hemostatic
test system
Prior art date
Application number
EA201900453A
Other languages
Russian (ru)
Other versions
EA201900453A2 (en
Inventor
Галина Геннадьевна Белозерская
Валерий Алексеевич Кабак
Евгений Михайлович Голубев
Татьяна Ивановна Широкова
Андрей Павлович Момот
Дмитрий Евгеньевич Белозеров
Марина Владимировна Пыхтеева
Ольга Евгеньевна Неведрова
Унан Левонович Джулакян
Лариса Сергеевна Малыхина
Дмитрий Юрьевич Бычичко
Асаф Рудольфович Лемперт
Максим Сергеевич Миронов
Original Assignee
Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр гематологии" Министерства здравоохранения Российской Федерации (ФГБУ "НМИЦ гематологии" Минздрава России)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр гематологии" Министерства здравоохранения Российской Федерации (ФГБУ "НМИЦ гематологии" Минздрава России) filed Critical Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр гематологии" Министерства здравоохранения Российской Федерации (ФГБУ "НМИЦ гематологии" Минздрава России)
Publication of EA201900453A2 publication Critical patent/EA201900453A2/en
Publication of EA201900453A3 publication Critical patent/EA201900453A3/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00—Sampling; Preparing specimens for investigation
    • G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Materials For Medical Uses (AREA)

Abstract

Изобретение относится к фармацевтической промышленности, а именно к оборудованию для проведения коагулологических, микробиологических и других лабораторных исследований in vitro. Описан тест на основе природного полимерного соединения для проведения лабораторных гемостатических исследований in vitro, включающий микропробирку и адгезивно связанную с ней исследуемую губку на основе природного полимерного соединения, полученную непосредственно в микропробирке путём сублимационной сушки. Технический результат: получен тест, применение которого позволяет уменьшить погрешность при проводимых экспериментах, исключить использование медицинского клея для закрепления пробы в микропробирке, а также упростит тестирование гемостатической активности in vitro в условиях производства кровоостанавливающих средств без проведения исследований на животных.The invention relates to the pharmaceutical industry, namely to equipment for coagulological, microbiological and other laboratory studies in vitro. Described is a test based on a natural polymeric compound for carrying out laboratory hemostatic studies in vitro, including a microtube and an adhesively bonded test sponge based on a natural polymeric compound, obtained directly in the microtube by freeze-drying. EFFECT: obtained test, the use of which allows to reduce the error in the experiments, exclude the use of medical glue to fix the sample in a microtube, and also simplify the testing of hemostatic activity in vitro in the production of hemostatic agents without conducting animal studies.

EA201900453A 2019-04-02 2019-09-27 TEST SYSTEM FOR STUDIES OF HEMOSTATIC PROPERTIES OF LOCAL WOUND COATINGS IN VITRO EA201900453A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2019109698A RU2695075C1 (en) 2019-04-02 2019-04-02 Test system for performing haemostatic properties of local wound coatings in vitro

Publications (2)

Publication Number Publication Date
EA201900453A2 EA201900453A2 (en) 2020-10-30
EA201900453A3 true EA201900453A3 (en) 2020-12-30

Family

ID=67309506

Family Applications (2)

Application Number Title Priority Date Filing Date
EA201900453A EA201900453A3 (en) 2019-04-02 2019-09-27 TEST SYSTEM FOR STUDIES OF HEMOSTATIC PROPERTIES OF LOCAL WOUND COATINGS IN VITRO
EA201900454A EA201900454A3 (en) 2019-04-02 2019-09-27 TEST SYSTEM FOR STUDIES OF HEMOSTATIC PROPERTIES OF LOCAL WOUND COATINGS IN VITRO

Family Applications After (1)

Application Number Title Priority Date Filing Date
EA201900454A EA201900454A3 (en) 2019-04-02 2019-09-27 TEST SYSTEM FOR STUDIES OF HEMOSTATIC PROPERTIES OF LOCAL WOUND COATINGS IN VITRO

Country Status (2)

Country Link
EA (2) EA201900453A3 (en)
RU (1) RU2695075C1 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4153512A (en) * 1976-04-07 1979-05-08 Fisher Scientific Company Storage stable antibiotic susceptibility test kit and method of testing
US20110204084A1 (en) * 1998-11-16 2011-08-25 Aronowitz Jack L Sample Collection System and Method for Use Thereof
RU2373532C1 (en) * 2008-09-09 2009-11-20 Андрей Алексеевич Нетяга Method of comparative estimate of haemostatic properties of surgical materials

Also Published As

Publication number Publication date
EA201900454A2 (en) 2020-10-30
EA201900453A2 (en) 2020-10-30
EA201900454A3 (en) 2020-12-30
RU2695075C1 (en) 2019-07-19

Similar Documents

Publication Publication Date Title
Becquart et al. Human mesenchymal stem cell responses to hydrostatic pressure and shear stress
Kizilay Mancini et al. Mitochondrial oxidative stress reduces the immunopotency of mesenchymal stromal cells in adults with coronary artery disease
Thayer et al. The effects of combined cyclic stretch and pressure on the aortic valve interstitial cell phenotype
AR113142A1 (en) MULTISPECIFIC ANTIGEN BINDING MOLECULES THAT HAVE SUBSTITUTION ACTIVITY FOR THE COFACTOR FUNCTION OF BLOOD COAGULATION FACTOR VIII (FVIII), AND PHARMACEUTICAL FORMULATIONS CONTAINING SUCH ACTIVE MOLECULE AS INGREDIENT
BR112015017307A2 (en) compositions of low acid species and methods for their production and use
Serrano et al. The S100A4 transcriptional inhibitor niclosamide reduces pro-inflammatory and migratory phenotypes of microglia: implications for amyotrophic lateral sclerosis
BR112016004320A2 (en) biosensor, system, kit, methods for determining or identifying and quantifying an ammonia or ammonium ion concentration, diagnosing a metabolic disease in a subject, determining a patient's response to therapy, making a biosensor, of a system or any test strip and detecting the presence, absence, or amount of amino acids in a sample, and test strip
Akerman et al. Elevated wall tension leads to reduced miR‐133a in the thoracic aorta by exosome release
Frauz et al. Transected tendon treated with a new fibrin sealant alone or associated with adipose-derived stem cells
Tricarico et al. Aquaporins are one of the critical factors in the disruption of the skin barrier in inflammatory skin diseases
Andrade et al. Hypoxic conditions promote the angiogenic potential of human induced pluripotent stem cell-derived extracellular vesicles
Jiménez-Moreno et al. Induced pluripotent stem cell neuronal models for the study of autophagy pathways in human neurodegenerative disease
Saitoh et al. Deficiency of a membrane skeletal protein, 4.1 G, results in myelin abnormalities in the peripheral nervous system
Wang et al. Upregulation of endothelial DKK1 (Dickkopf 1) promotes the development of pulmonary hypertension through the Sp1 (specificity protein 1)/SHMT2 (serine hydroxymethyltransferase 2) pathway
Hatzmann et al. Quiescence, stemness and adipogenic differentiation capacity in human DLK1−/CD34+/CD24+ adipose stem/progenitor cells
Wang et al. Pre-conditioning with IFN-γ and hypoxia enhances the angiogenic potential of iPSC-derived MSC secretome
CO2023017156A2 (en) Anti-sirp-alpha antibodies
EA201900453A3 (en) TEST SYSTEM FOR STUDIES OF HEMOSTATIC PROPERTIES OF LOCAL WOUND COATINGS IN VITRO
BR112019010034A2 (en) targeted red blood cell factor viii and method of use
Cambronero-Urena et al. Polyhexamethylene guanidine phosphate, chloromethylisothiazolinone, and particulate matter are dispensable for stress granule formation in human airway epithelial cells
Bickford et al. Nutraceutical intervention reverses the negative effects of blood from aged rats on stem cells
Saxena et al. Portable, low‐cost hypoxia chamber for simulating hypoxic environments: Development, characterization and applications
Kummer et al. Inflammasome in skeletal muscle: NLRP3 is an inflammatory cell stress component in inclusion body myositis
CY1122955T1 (en) DETERMINATION OF SARCOSINE USING SARCOSINE OXIDATION AND HORSEHORSE PEROXIDATION ATTACHED TO FE2O3/AU NANOPARTICLES THROUGH CHITOSAN
Lee et al. Evaluation of the Age-and Sex-Related Changes of the Osteogenic Differentiation Potentials of Healthy Bone Marrow-Derived Mesenchymal Stem Cells